Open access · CC-BY
via OpenAlex
Dasatinib plus quercetin attenuates some frailty characteristics in SAMP10 mice
Scientific Reports · 2022 · ▲ 32 citations
Abstract
Senolytics(definition) are a class of drugs that selectively remove senescent cells. Dasatinib and quercetin have been discovered, and their combination has shown various anti-ageing effects. The SAMP10 mouse strain is a model of brain ageing. Here, we investigated the effect of combination on frailty characteristics in SAMP10. By comparing SAMP10 with SAMR1 mice as normal ageing controls, we investigated some frailty characteristics. Frailty was assessed at 18-38 weeks of age with a clinical frailty index. Motor and cognitive function of these mice were evaluated using behavioral experiments. SAMP10 mice were divided into vehicle and combination, and these functions and histological changes in the brain hippocampus were investigated. Finally, the in vitro effects of combination on oxidative stress-induced senescent muscle and neuronal cells were investigated. As a result, we found that frailty index was higher in SAMP10 than SAMR1. Motor and cognitive function were worse in SAMP10 than SAMR1. Furthermore, combination therapy improved frailty, motor and cognitive function, and the senescent phenotype of the hippocampus compared with vehicle in SAMP10. In summary, SAMP10 showed more marked frailty characteristics than SAMR1, and dasatinib and quercetin attenuated them in SAMP10. From our results, senolytic therapy might contribute protective effects against frailty.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1038/s41598-022-06448-5
- Canonical
- link ↗
- Fetched
- 2026-06-18 MST
Cite this
APA
Ota, H., & Kodama, A. (2022). Dasatinib plus quercetin attenuates some frailty characteristics in SAMP10 mice. <em>Scientific Reports</em>. https://doi.org/10.1038/s41598-022-06448-5
Vancouver
Ota H, Kodama A. Dasatinib plus quercetin attenuates some frailty characteristics in SAMP10 mice. Scientific Reports. 2022. doi:10.1038/s41598-022-06448-5.
BibTeX
@article{hidetaka2022Dasati,
title = {Dasatinib plus quercetin attenuates some frailty characteristics in SAMP10 mice},
author = {Hidetaka Ota and Ayuto Kodama},
journal = {Scientific Reports},
year = {2022},
doi = {10.1038/s41598-022-06448-5},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Research Square 2025
Preprint · CC-BY
Dasatinib and quercetin senolytic treatment delays early onset intervertebral disc degeneration in SM/J mice
Nature Aging 2022
Preprint · CC-BY
A machine-vision-based frailty index for mice
Institutional Repositories DataBase (IRDB) 2025
Preprint · CC-BY
ダサチニブとケルセチンは老化細胞除去剤として、代謝機能障害関連脂肪性肝疾患メダカモデルにおいて脂肪沈着の改善、抗線維化効果を示す
Scientific Reports 2025
Open access · CC-BY
Comparison of the frailty phenotype and frailty index for identifying vulnerable companion dogs
Mechanisms of Ageing and Development 2008
Citation only
Telomeres and frailty
Diseases 2024
Open access · CC-BY